Hospital
Mission Hospital Regional Medical Center
Mission Hospital Regional Medical Center was paid $10.09M by Medicaid between Jan 2018 and Dec 2024, across 242 billing codes. Its largest line is 0450, Emergency room services — 9.6% of everything it billed.
33Billing provider infoMISSION HOSPITAL REGIONAL MEDICAL CENTER
MISSION VIEJO, CA 92691
MISSION VIEJO, CA 92691
33aNPI1912108002assigned 05/29/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.09M
24GClaims548,533
24DCodes billed242
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#178 of 410
Median peer was paid$6.90M
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 91,239 | $820K | |
| 2019 | 60,777 | $1.05M | |
| 2020 | 67,351 | $984K | |
| 2021 | 65,786 | $1.11M | |
| 2022 | 84,158 | $1.49M | |
| 2023 | 102,159 | $2.01M | |
| 2024incomplete | 77,063 | $2.63M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 9.6% | 40,414 | 34,695 | $964K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 6.3% | 6,004 | 5,529 | $632K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.3% | 13,659 | 11,753 | $631K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.1% | 7,816 | 6,675 | $409K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.9% | 1,990 | 1,865 | $393K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.8% | 6,073 | 5,675 | $380K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3.5% | 11,555 | 8,868 | $353K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3.4% | 3,007 | 2,982 | $341K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.2% | 17,284 | 15,189 | $326K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.9% | 5,031 | 4,575 | $291K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2.3% | 2,326 | 2,208 | $229K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 2.2% | 4,061 | 2,925 | $225K |
230 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 33,905 | $204K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2.0% | 1,085 | $201K |
| 80053 | Comprehensive metabolic panel | 2.0% | 23,426 | $199K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.5% | 2,995 | $154K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 2,755 | $152K |
| 76830 | Ultrasound, transvaginal | 1.5% | 2,798 | $151K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.5% | 5,756 | $148K |
| 83880 | 1.4% | 5,634 | $141K | |
| J3490 | Unclassified drugs | 1.4% | 30,300 | $139K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 12,649 | $134K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 5,814 | $128K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.1% | 2,612 | $113K |
| 99199 | Unlisted special service, procedure or report | 1.1% | 1,624 | $110K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1.1% | 2,249 | $109K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.1% | 604 | $106K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.0% | 3,963 | $106K |
| 84484 | <1% | 12,184 | $98K | |
| 77066 | Tomosynthesis, mammo | <1% | 680 | $97K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,593 | $93K |
| 93971 | <1% | 711 | $85K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 3,030 | $85K |
| 83690 | <1% | 12,209 | $64K | |
| Z7502 | <1% | 1,670 | $64K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,072 | $60K |
| Z9725 | <1% | 1,350 | $58K | |
| 0160 | <1% | 2,533 | $57K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 10,078 | $57K |
| 76641 | <1% | 702 | $54K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,862 | $51K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,436 | $50K |
| 84145 | <1% | 2,516 | $50K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,881 | $48K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 586 | $47K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 558 | $45K |
| 93976 | <1% | 902 | $42K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 437 | $38K |
| 99283 | Emergency room visit (moderate) | <1% | 1,472 | $36K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 6,948 | $36K |
| 73630 | <1% | 1,633 | $36K | |
| 93970 | <1% | 157 | $36K | |
| 76801 | <1% | 576 | $35K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 476 | $35K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 287 | $34K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 308 | $33K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 11,103 | $33K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,778 | $29K |
| 81001 | <1% | 12,328 | $29K | |
| 76642 | <1% | 446 | $29K | |
| 87040 | <1% | 2,940 | $28K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 913 | $28K |
| 82553 | <1% | 3,852 | $28K | |
| 83605 | <1% | 3,263 | $28K | |
| 0760 | <1% | 1,700 | $26K | |
| 83735 | <1% | 5,319 | $26K | |
| 72131 | <1% | 373 | $25K | |
| 90715 | <1% | 746 | $24K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 825 | $23K |
| 73562 | <1% | 1,005 | $22K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,266 | $21K |
| 82550 | <1% | 4,907 | $21K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,799 | $21K |
| 72100 | <1% | 842 | $21K | |
| 73030 | <1% | 949 | $20K | |
| 70486 | <1% | 236 | $20K | |
| 71250 | <1% | 223 | $20K | |
| 84702 | <1% | 3,373 | $20K | |
| 97750 | <1% | 318 | $19K | |
| 73610 | <1% | 874 | $19K | |
| 87631 | <1% | 422 | $19K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 119 | $17K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 718 | $17K |
| 85379 | <1% | 2,026 | $15K | |
| 85610 | <1% | 5,373 | $14K | |
| 84703 | <1% | 5,929 | $14K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,432 | $13K |
| 80076 | <1% | 2,438 | $13K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 151 | $13K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 327 | $12K |
| 59025 | Fetal non-stress test | <1% | 863 | $12K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 65 | $12K |
| 77065 | Tomosynthesis, mammo | <1% | 109 | $11K |
| 77080 | <1% | 307 | $11K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,634 | $11K |
| 85730 | <1% | 2,883 | $11K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,918 | $10K |
| 73130 | <1% | 460 | $10K | |
| 85027 | <1% | 2,166 | $10K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,635 | $10K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 3,102 | $10K |
| 80047 | <1% | 2,069 | $10K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,659 | $9K |
| 72141 | <1% | 87 | $9K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 372 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 918 | $8K |
| 81025 | <1% | 2,362 | $8K | |
| 72128 | <1% | 136 | $8K | |
| 87077 | <1% | 994 | $7K | |
| 86901 | <1% | 3,072 | $7K | |
| 81003 | <1% | 6,694 | $7K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 967 | $7K |
| 86900 | <1% | 3,070 | $7K | |
| 70496 | <1% | 25 | $6K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 75 | $6K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 657 | $6K |
| 86140 | <1% | 1,540 | $6K | |
| 87186 | <1% | 903 | $6K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,675 | $6K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 969 | $6K |
| 94760 | <1% | 1,359 | $5K | |
| 0270 | <1% | 32,968 | $5K | |
| 86850 | <1% | 2,101 | $5K | |
| 97139 | <1% | 356 | $5K | |
| 87081 | <1% | 1,269 | $5K | |
| 73110 | <1% | 231 | $5K | |
| 82150 | <1% | 1,630 | $5K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,862 | $5K |
| 96376 | <1% | 5,128 | $4K | |
| 84100 | <1% | 1,311 | $4K | |
| 82947 | <1% | 2,415 | $3K | |
| 80143 | <1% | 136 | $3K | |
| 80179 | <1% | 133 | $3K | |
| 74018 | <1% | 230 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 774 | $3K |
| A4217 | Sterile water/saline, 500 ml | <1% | 503 | $3K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 531 | $3K |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 374 | $3K |
| 85652 | <1% | 1,178 | $2K | |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 200 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 270 | $2K |
| 93017 | <1% | 44 | $2K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 13 | $2K |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 225 | $2K |
| 97802 | <1% | 14 | $2K | |
| J1815 | Injection, insulin, per 5 units | <1% | 73 | $2K |
| G0202 | Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | <1% | 42 | $2K |
| 76536 | <1% | 33 | $1K | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 143 | $1K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 611 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 180 | $1K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 170 | $1K |
| 96367 | <1% | 46 | $1K | |
| 85007 | <1% | 640 | $1K | |
| 84439 | <1% | 174 | $937.57 | |
| 86141 | <1% | 230 | $931.83 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 205 | $922.53 |
| 71020 | <1% | 48 | $898.92 | |
| J3535 | Drug administered through a metered dose inhaler | <1% | 40 | $892.95 |
| 71010 | <1% | 118 | $818.95 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 831 | $811.14 |
| 73590 | <1% | 40 | $755.90 | |
| 76770 | <1% | 12 | $741.00 | |
| 87205 | <1% | 351 | $736.30 | |
| 73080 | <1% | 30 | $702.46 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 135 | $698.31 |
| 72170 | <1% | 47 | $691.58 | |
| Z7610 | <1% | 126 | $659.75 | |
| 85014 | <1% | 744 | $608.79 | |
| 76870 | <1% | 13 | $598.39 | |
| 73502 | <1% | 16 | $568.41 | |
| 87420 | <1% | 176 | $540.64 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 136 | $529.62 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 114 | $529.20 |
| 87070 | <1% | 144 | $509.35 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 17 | $486.80 |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 44 | $445.82 |
| 72040 | <1% | 12 | $444.47 | |
| 0250 | <1% | 1,199 | $383.47 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 44 | $382.80 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 42 | $326.50 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 41 | $319.50 |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 12 | $309.60 |
| 0710 | <1% | 951 | $287.42 | |
| 99285 | Emergency room visit (most serious) | <1% | 49 | $270.41 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 32 | $248.00 |
| 82077 | <1% | 24 | $228.55 | |
| 0258 | <1% | 706 | $191.06 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 72 | $189.05 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 290 | $185.54 |
| 82248 | <1% | 60 | $182.23 | |
| 0761 | <1% | 226 | $170.50 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 71 | $170.43 |
| 87430 | <1% | 46 | $170.04 | |
| 10060 | <1% | 17 | $165.00 | |
| 80061 | Lipid panel | <1% | 53 | $164.62 |
| 99070 | <1% | 284 | $160.04 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 74 | $156.69 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 36 | $154.79 |
| 82728 | <1% | 32 | $148.80 | |
| 0360 | <1% | 524 | $146.17 | |
| 83615 | <1% | 41 | $125.15 | |
| 0272 | <1% | 829 | $120.80 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 18 | $113.36 |
| 12001 | <1% | 13 | $112.80 | |
| 80050 | General health panel | <1% | 94 | $103.95 |
| 87147 | <1% | 38 | $103.11 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 33 | $67.70 |
| 99152 | <1% | 15 | $65.31 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 12 | $63.65 |
| 87075 | <1% | 13 | $57.94 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 381 | $57.50 |
| 87210 | <1% | 23 | $45.94 | |
| 0637 | <1% | 50 | $39.62 | |
| 86308 | <1% | 13 | $32.31 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 551 | $29.56 |
| 94664 | <1% | 75 | $24.68 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 8,154 | $16.81 |
| S0028 | Injection, famotidine, 20 mg | <1% | 134 | $8.84 |
| 0636 | 0% | 266 | $0.00 | |
| 0307 | 0% | 80 | $0.00 | |
| 0305 | 0% | 121 | $0.00 | |
| 0352 | 0% | 99 | $0.00 | |
| 0301 | 0% | 821 | $0.00 | |
| 0350 | 0% | 14 | $0.00 | |
| 0324 | 0% | 114 | $0.00 | |
| C9399 | Unclassified drugs or biologicals | 0% | 26 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 17 | $0.00 |
| 0306 | 0% | 180 | $0.00 | |
| 0922 | 0% | 12 | $0.00 | |
| C1769 | Guide wire | 0% | 16 | $0.00 |
| 0949 | 0% | 67 | $0.00 | |
| 77062 | 0% | 125 | $0.00 | |
| 0300 | 0% | 513 | $0.00 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 0% | 30 | $0.00 |
| 0351 | 0% | 58 | $0.00 | |
| 0762 | 0% | 317 | $0.00 | |
| 0403 | 0% | 40 | $0.00 | |
| 0302 | 0% | 28 | $0.00 | |
| 0402 | 0% | 154 | $0.00 | |
| 0320 | 0% | 116 | $0.00 | |
| 0489 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.